Previous Page  13 / 28 Next Page
Information
Show Menu
Previous Page 13 / 28 Next Page
Page Background

Pathology 2018

Research & Reviews: Journal of Medical and Health Sciences

ISSN: 2319-9865

Page 68

October 08-09, 2018

Edinburgh, Scotland

17

th

International Conference on

Pathology & Cancer

Epidemiology

Objective:

Several phenotype variants of factor B (FB) can be

identified in human serum. We have previously shown that

there are differences in concentration and activity of various

phenotypes FB. It was also observed that during serum storage

a slow conversion rate between FB phenotypes is accelerated at

37℃. The purpose of this work is to determine the difference of

conversion rate between different FB phenotype variants.

Methodology:

107 serum samples of healthy individuals

were investigated. Electrophoresis with immuno fixation was

used for phenotyping. Activity of FB was determined using

the kinetic, nephelometric test with FB deficient serum. RID

and electro immuno assay were used for determination of FB

concentration. C3 component conversion was investigated by

cross- electrophoresis.

Results:

In analyzed samples 60 SS, 43 FS, 3 FF and one F1S

phenotype was found. Three serum samples of each phenotype

were stored at 37ºC. After 24 h, 3 and 7 days in each sample FB

concentration and activity and complement alternative pathway

activity were determined. During conversion it was noticed that

complement activity was lost on the 7th day, while FB activity

remained unchanged. Using cross-electrophoresis we found that

on 7th day, C3 component was completely converted leading to

the loss of complement hemolytic activity.

Conclusion:

Phenotype FF had the fastest conversion rate,

FS phenotype slower and the slowest conversion rate had SS

phenotype. The differences were most obvious on the third day

of conversion. Various FB phenotypes had no influence on C3

component conversion.

gagabeg@gmail.com

Spontaneous

in vitro

conversion of various phenotype forms of

factor B

Dragana Begovic

and

Dragisa Misovic

Clinical Health Center, Belgrade, Serbia

RRJMHS 2018

Volume: 7